MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-18-2025
Helius Medical Technologies Operating Income 2011-2026 | HSDT
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Helius Medical Technologies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12.4 M | -15.5 M | -18.1 M | -14.4 M | -24 M | -26.7 M | -22.9 M | -9.32 M | -9.81 M | -1.07 M | -8.52 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.07 M | -26.7 M | -14.8 M |
Quarterly Operating Income Helius Medical Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -35.4 M | -3.32 M | -4.01 M | - | -4.07 M | -3.27 M | -3.42 M | - | -3.15 M | -3.22 M | -3.81 M | - | -4.85 M | -3.43 M | -4.56 M | - | -4.37 M | -6.17 M | -3.5 M | - | -3.66 M | -3.72 M | -4 M | - | -5.74 M | -5.81 M | -6.82 M | - | -4.89 M | -11.8 M | -4.72 M | - | -5.97 M | -5.98 M | -5.03 M | - | -3.39 M | -2.1 M | -2.92 M | -2.84 M | -726 K | -3.71 M | - | -3.09 M | -3.09 M | -2.76 M | -1.38 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -726 K | -35.4 M | -4.99 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M |  USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Quanterix Corporation
QTRX
|
-126 M | $ 3.7 | -5.26 % | $ 158 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Sensus Healthcare
SRTS
|
-10.3 M | $ 3.82 | -4.74 % | $ 62.4 M | USA |
 |
Stryker Corporation
SYK
|
4.89 B | $ 329.18 | -1.05 % | $ 126 B | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Tactile Systems Technology
TCMD
|
29.3 M | $ 26.39 | -1.46 % | $ 604 M | USA |
 |
TELA Bio
TELA
|
-33.8 M | $ 0.66 | -11.53 % | $ 31 M | USA |
 |
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Tandem Diabetes Care
TNDM
|
8.29 M | $ 21.83 | -6.39 % | $ 1.48 B | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 35.75 | -2.43 % | $ 1.11 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-56.7 M | $ 2.22 | -2.24 % | $ 130 M |  Israel |
 |
Viemed Healthcare
VMD
|
22.9 M | $ 9.34 | 1.3 % | $ 363 M | USA |
 |
Varex Imaging Corporation
VREX
|
-27.8 M | $ 10.84 | 0.56 % | $ 449 M | USA |
 |
NanoVibronix
NAOV
|
-3.58 M | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
9.66 M | $ 24.52 | 0.02 % | $ 207 M | USA |
 |
Vivos Therapeutics
VVOS
|
-11.2 M | $ 1.17 | -1.62 % | $ 5.87 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Beyond Air
XAIR
|
-44.5 M | $ 0.69 | -0.32 % | $ 46.7 M | USA |
 |
Outset Medical
OM
|
-66.7 M | $ 3.39 | -3.84 % | $ 51.6 K | USA |
 |
Zimmer Biomet Holdings
ZBH
|
1.29 B | $ 88.49 | -0.74 % | $ 18 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-16.8 M | $ 0.6 | -0.02 % | $ 32.7 M | USA |
 |
Aethlon Medical
AEMD
|
-9.34 M | $ 2.23 | -1.76 % | $ 3.48 M | USA |
 |
PAVmed
PAVM
|
-68.8 M | $ 8.53 | -4.59 % | $ 61.7 M | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
InspireMD
NSPR
|
-49.6 M | $ 1.65 | -4.62 % | $ 106 M | Israel |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 11.24 | -1.49 % | $ 1.52 B | USA |
 |
Penumbra
PEN
|
189 M | $ 335.29 | -0.34 % | $ 13 B | USA |
 |
MiMedx Group
MDXG
|
63.9 M | $ 3.87 | -1.9 % | $ 572 M | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
-27 M | - | 10.0 % | $ 610 K | USA |
 |
Myomo
MYO
|
-14.4 M | $ 0.68 | 0.18 % | $ 28.5 M | USA |
 |
Inspire Medical Systems
INSP
|
51 M | $ 49.36 | -2.16 % | $ 1.45 B | USA |